TARE / Y-90 Radioembolization
Oncology
Daga
$9,000
Har zuwa $28,000 ya danganta da cibiya
Tsawon lokaci na yau da kullum
5–10 days
Hada da gwaje-gwajen kafin tiyata
An bincika wannan abun ciki don daidaiton likitanci daga: Dr. Rodina Ainasoa · Marubuciyar Likitanci & Sadarwar Lafiya
Bayyani
Transarterial radioembolization (TARE) delivers radioactive Yttrium-90 (Y-90) microspheres directly into the artery feeding a liver tumour through a catheter placed via the groin or wrist. Unlike TACE, which uses chemotherapy-soaked particles to block blood flow, TARE relies on localised beta radiation emitted by the microspheres to destroy tumour tissue from within while largely sparing healthy liver, making it an option for patients with unresectable hepatocellular carcinoma or liver metastases, including some with portal vein thrombosis unsuitable for TACE.
Ana daidaita al'amarinku da cibiya bisa bayanan sakamako na likitanci, ba talla ba. Muna tsara kowane mataki — daga gwaje-gwajen kafin tiyata zuwa biye-biye bayan jiyya — tare da mai tsara kulawa na musamman.
Abinda ya hada
TARE / Y-90 Radioembolization
An tsara daga
ko aiko mana sako a kan WhatsApp
Ba a bukatar alkawari. Ba a taba raba bayananku da wasu jam'iyyu ba.
Fahimtar TARE / Radioembolization na Y-90
Transarterial radioembolization (TARE) tana kaiwa ƴan ƙwallaye masu radiyoaktif na Yttrium-90 (Y-90) ta wani catheter da aka sanya a jijiyar hanta. Sabanin TACE, wanda ya haɗa chemotherapy da tasirin toshewa, TARE ta fi dogaro da radiyo na beta na wuri ɗaya don lalata ƙwayoyin ƙumburi, tare da ƴar tasirin toshewa ƙasa da haka — wannan shi ne dalilin da yasa za a iya amfani da ita ga wasu marasa lafiya masu portal vein thrombosis inda TACE zai yi haɗari.
Ƴan Ƙwallaye na Resin Y-90 (SIR-Spheres)
Ana zuba ƴan ƙwallaye ƙanana na resin ɗauke da Y-90 zuwa cikin jijiyar da take ciyar da ƙumburi; galibi ana amfani da adadi mafi girma na ƴan ƙwallaye a kowace zama idan an kwatanta da ƴan ƙwallaye na gilashi.
Ƴan Ƙwallaye na Gilashi Y-90 (TheraSphere)
Ƴan ƙwallaye na gilashi suna ɗauke da radiyoaktif mafi girma a kowace ƴar ƙwallo, wanda yake ba da damar amfani da ƴan ƙwallaye kaɗan don kai adadin da ake bukata na ƙumburi, kuma galibi ana amfani da su don dabarun magani na wuri ɗaya, adadi mai girma kamar radiation segmentectomy.
Radiation Segmentectomy da Lobectomy
Wata hanya ta TARE mai nufi sosai kuma da manufar lalatawa wanda take kaiwa adadin radiyo mai girma zuwa sashi ɗaya ko biyu na hanta (segmentectomy) ko dukkan lobe (lobectomy), ana amfani da ita ga ƙananan ƙumburi inda manufa ta adadin wuri ɗaya na warkarwa ce.
Tsarin Magani: Mataki bayan Mataki
Galibi ana kai TARE a matakai biyu: zaman shirya taswira/tsara da zaman magani ɗaya ko fiye, wanda ƙungiyar radiology mai shiga tsakani da hepato-oncology naku suka tabbatar bisa hotunanku da aikin hanta.
Angiogram na Taswira da Nazarin Shunt na Huhu
Ana sanya catheter cikin jijiyar hanta ta hanyar makwarara ko ƴar hannu don yin taswirar ciyarwar jinin ƙumburi, kuma ana zuba ƴar adadin technetium-99m (Tc-99m MAA) don auna yawan jinin da za a tura zuwa huhu, wanda yake tantance adadin Y-90 mai aminci.
Tsara Dosimetry
Likitan radiology mai shiga tsakani da likitan nuclear medicine suna lissafta adadin Y-90 na kowane majiyyaci bisa girman ƙumburi, girman hanta, da kason shunt na huhu da aka auna a nazarin taswira.
Zuba Ƴan Ƙwallaye na Y-90
A wani zaman daban, galibi mako ɗaya zuwa uku bayan taswira, ana sake sanya catheter a wannan jijiya kuma an zuba adadin ƴan ƙwallaye na resin ko gilashi na Y-90 da aka lissafta, galibi a matsayin harka ta rana ɗaya ko ɗan ƴar kwana a asibiti.
Hoto Bayan Magani
Ana iya yin hoto (kamar Bremsstrahlung SPECT/CT ko PET/CT) jim kaɗan bayan zuba don tabbatar da cewa ƴan ƙwallaye sun isa yankin ƙumburi da aka shirya.
Farfaɗowa da Tsarin Bin Diddigi
Galibin marasa lafiya ana kula da su na ƴan awanni bayan zuba don sa idanu kan alamun rayuwa da wurin catheter kafin yanke shawarar fita a ranar ko ɗan ƴar kwana a asibiti.
Gajiya ƴar kaɗan, zazzabi ƴar kaɗan, tashin zuciya, ko rashin jin daɗi na ciki (post-radioembolization syndrome ƴar kaɗan) na iya faruwa a mako na farko kuma galibi ana kula da su da magani mai sauƙi.
Galibin marasa lafiya suna komawa aikin yau da kullum a cikin mako ɗaya zuwa biyu; galibi ana sake duba gwajin aikin hanta don tabbatar da cewa hanta da aka yi wa magani tana jurewa da adadin radiyo.
Ana tsara hoto na bin diddigi na MRI ko CT mai contrast don tantance amsar ƙumburi, tare da ainihin tsarin da kowane zaman magani na ƙari da ƙungiyar radiology mai shiga tsakani da oncology naku suka tsara.
Tushen: kayan ilimin marasa lafiya na Society of Interventional Radiology (SIR); babin StatPearls na NCBI/PMC kan transarterial radioembolization; taƙaitawar maganin cutar kansar hanta na American Cancer Society. Tsarin lokaci na kowane mutum ya bambanta kuma ƙungiyar kula da ku ce take shiryawa.
Haɗari da Iyakoki da Aka Sani
- Kamar kowace hanya ta catheter ta jijiya, akwai ƴar haɗarin zub da jini, kamuwa da cuta, ko rauni na jijiya a wurin shiga ko tare da hanyar catheter zuwa hanta.
- Cutar hanta da radiyo ya jawo ita ce matsala da aka sani amma ba ta zama ruwan dare, musamman ga marasa lafiya masu ƴar aikin hanta tun farko, wannan shi ne dalilin da yasa ake tantance aikin hanta a hankali kafin magani.
- Toshewa da ba a nufa ba — ƴan ƙwallaye da suka kai huhu, ciki, ko hanji — ita ce iyaka da aka sani wanda angiogram na taswira da nazarin shunt na huhu an tsara su musamman don gano su da rage su tun da wuri.
- TARE magani ne na wuri ɗaya, mai nufin hanta — ba ya magance yaɗuwar ƙumburi zuwa waje da hanta, don haka galibi ana haɗa ta da bin diddigi ko magani na tsari ga cutar da ta yaɗu fiye da hanta.
Tushen: Society of Interventional Radiology (SIR), NCBI/PMC StatPearls, da nazarce-nazarcen sakamakon radioembolization da aka bita akan PubMed/PMC. Babu tsarin magani da babu haɗari; ƙungiyar kula da ku za ta duba abubuwan haɗarinku kafin ba da shawarar hanya.
Tsarin Kula da CureSureMedico
Bita na Asibiti Daga Nesa
Raba hotunan hanta naku na kwanan nan (CT/MRI), sakamakon alamar ƙumburi AFP, da gwajin aikin hanta. Ƙungiyar tsari namu za ta tura al'amarin ku ga likitan radiology mai shiga tsakani da ƙungiyar hepato-oncology don bita na farko kafin ku tafi.
Zaɓin Dabara na Ƴan Kwararru Daban-daban
Ƙungiyar da ta karɓa za ta duba girman ƙumburi naku, adadi, da tsarin jijiyoyi, da aikin hanta naku, don tabbatar da TARE ta dace da ko hanyar resin, gilashi, ko radiation segmentectomy/lobectomy ta fi dacewa.
Tsarin Magani Haɗe da Kimanta Kuɗi
Ana bayar da kimanta kuɗi wanda ya haɗa da angiogram na taswira, tsara dosimetry, zaman(zaman) magani, da duk kwana a asibiti kafin ku tafi, tare da bayyana tsarin lokaci da haɗarin da ake tsammani a fili.
Zaman Taswira da Magani
Kuna halartar zaman taswira/nazarin shunt na huhu, sannan ku dawo makonni kaɗan bayan haka don zuba Y-90 kanta, tare da farfaɗowa ƴar taƙaitacce bayan kowane zama.
Hoto na Bibiya da Mika Wuya ga Oncology
Ana shirya taƙaitaccen fitowa da tsarin hoto na bibiya ga ƙungiyar oncology naku ta gida, tunda tabbatar da amsar ƙumburi da bin diddigin aikin hanta yana ci gaba tsawon lokaci bayan kun dawo gida.
Kwatancen farashi na duniya — TARE / Y-90 Radioembolization
Matsakaicin farashi da aka tsara a fadin cibiyoyinmu na hadin gwiwa. Farashin karshe ya danganta da tsananin yanayi da asibitin da aka zaba.
| Kasa | Matsakaicin farashi | idan aka kwatanta da mafi araha |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $9,500 | —chevron_right |
🇹🇷 Turkey Istanbul | $17,000 | +79%chevron_right |
🇹🇭 Thailand Bangkok · Phuket · Chiang Mai | $21,000 | +121%chevron_right |
Farashi kimantawa ne kuma yana bambanta bisa ga cikakkun bayanan aikin, asibiti, da tsananin yanayin likita. Nemi kimar musamman don al'amarinku.
Tambayoyin da ake yawan yi
Both are catheter-based liver-directed therapies delivered through the hepatic artery, but they work differently. TACE (transarterial chemoembolisation) injects chemotherapy-soaked particles that also block the tumour's blood supply. TARE (radioembolisation) injects radioactive Y-90 microspheres that stay in place and irradiate the tumour with beta radiation over days to weeks, with less immediate blood-flow blockage — which is why TARE is often used for tumours or portal vein involvement where TACE's embolic effect would be unsafe.
Babu kudi. Babu alkawari.
Jagoranmu kyauta ne gaba daya
Asibitocinmu na hadin gwiwa ne suke biyanmu — ba majinyata ba. Kuna samun daidaita likitanci mai zaman kansa, bayyana farashi, da cikakken tsari ba tare da kudi a kanku ba.